Latest Feature

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Debate heats up during FDA meeting over uterine surgical device and cancer risk

July 11, 2014 by Ingrid Mezo

A public meeting over the potential risks of laparoscopic power morcellators draws passionate perspectives from patients and physicians affected by the surgical devices.

Debate heats up during FDA meeting over uterine surgical device and cancer risk

Scores of speakers expressed outrage before a panel of FDA experts gathered at a public meeting yesterday and today to discuss the future of laparoscopic power morcellators (LPMs), devices used to break up and extract tissue during minimally invasive gynecologic  surgeries.

MassDevice.com +3 | The top 3 medtech stories for July 11, 2014

July 11, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Robot surgery becomes a poster child for curbing new health tech

July 11, 2014 by Arezu Sarvestani

Researchers use Intuitive Surgical's da Vinci robotic surgery system as a cautionary tale about the rapid adoption of new technologies that require physician training.

Robot surgery becomes a poster child for curbing new health tech

Valve-in-valve surgery shows promise in new registry study

July 11, 2014 by Arezu Sarvestani

An new study shows that transcatheter aortic valve-in-valve implantation may be an important option for a growing population of patients with deteriorating bioprosthetic implants, but outcomes depend strongly on how the previous valve is failed.

Medtronic and Edwards implants show promise in valve-in-valve treatment

New research released this week provides more support for the use of transcatheter aortic valve-in-valve (VIV) implantation as a means of replacing previously implanted valves that have deteriorated over time.

Warning letter prompts lawsuit against Staar Surgical

July 11, 2014 by Brad Perriello

A shareholder files a purported class action lawsuit against Staar Surgical over an FDA warning letter issued in May for violations found at its Monrovia, Calif., plant.

Warning letter prompts lawsuit against Staar Surgical

Covidien logs $180M charge over pelvic mesh lawsuits

July 11, 2014 by Brad Perriello

Covidien says its exposure to a raft of product liability lawsuits filed over pelvic mesh products increased by some $131 million during its fiscal 3rd quarter.

Covidien logs $180M charge over pelvic mesh lawsuits

BSX invests $15M in Mvalve Technologies | Medtech funding for the week of July 7, 2014

July 11, 2014 by MassDevice

Here's a look at some of the top funding stories for medical device companies this week: Report: Stealthy Mvalve raises $15M from Boston Scientific; Veran Medical nears close of $7.5M round in support of airway imaging; Gynesonics adds $6M for fibroid device; Digital health startups already raked in $2.3B this year; Cardiac Insight raises $7M

Report: Stealthy Mvalve raises $15M from Boston Scientific

July 7, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp